EX-10.12 2 dex1012.htm SECOND AMENDED AND RESTATED EXCLUSIVE PURCHASE AND SUPPLY AGREEMENT ***Text Omitted and Filed Separately with the Securities and Exchange Commission CONFIDENTIAL TREATMENT REQUESTED UNDER 17 C.F.R. 200.80(B)(4) AND 230.406...Exclusive Purchase and Supply Agreement • May 5th, 2020 • Texas
Contract Type FiledMay 5th, 2020 JurisdictionThis SECOND AMENDED and RESTATED EXCLUSIVE PURCHASE AND SUPPLY AGREEMENT (the “AGREEMENT”) is made and entered into as of the 16th day of August 2007 by and between Austin Pharma, LLC, a Texas limited liability company, having an address at 811 Paloma Drive, Round Rock, Texas 78664 (“APL”) and Insys Therapeutics, Inc., a Delaware corporation having an address at 10220 South 51st Street, Suite 2, Phoenix, Arizona 85044-5231 (“INSYS”) and shall have effect from the EFFECTIVE DATE hereof.
SECOND AMENDED AND RESTATED EXCLUSIVE PURCHASE AND SUPPLY AGREEMENTExclusive Purchase and Supply Agreement • October 2nd, 2007 • Insys Therapeutics, Inc. • Pharmaceutical preparations • Texas
Contract Type FiledOctober 2nd, 2007 Company Industry JurisdictionThis SECOND AMENDED and RESTATED EXCLUSIVE PURCHASE AND SUPPLY AGREEMENT (the “AGREEMENT”) is made and entered into as of the 16th day of August 2007 by and between Austin Pharma, LLC, a Texas limited liability company, having an address at 811 Paloma Drive, Round Rock, Texas 78664 (“APL”) and Insys Therapeutics, Inc., a Delaware corporation having an address at 10220 South 51st Street, Suite 2, Phoenix, Arizona 85044-5231 (“INSYS”) and shall have effect from the EFFECTIVE DATE hereof.